CD24抗體詳細說明書

【資料簡介】

產品介紹    This gene encodes a sialoglycoprotein that is expressed on mature granulocytes and in many B cells. The encoded protein is anchored via a glycosyl phosphatidylinositol (GPI) link to the cell surface. [provided by RefSeq, Jul 2008].
Function : Modulates B-cell activation responses. Signaling could be triggered by the binding of a lectin-like ligand to the CD24 carbohydrates, and transduced by the release of second messengers derived from the GPI-anchor. Promotes AG-dependent proliferation of B-cells, and prevents their terminal differentiation into antibody-forming cells.
Subunit : Belongs to the CD24 family.
Subcellular Location : Cell membrane.
Tissue Specificity : B-cells. Expressed in a number of B-cell lines including P32/SH and Namalwa. Expressed in erythroleukemia cell and small cell lung carcinoma cell lines. Also expressed on the surface of T-cells.
Post-translational modifications : Extensively O-glycosylated.
DISEASE : Genetic variations in CD24 are associated with susceptibility to multiple sclerosis (MS). A multifactorial, inflammatory, demyelinating disease of the central nervous system. Sclerotic lesions are characterized by perivascular infiltration of monocytes and lymphocytes and appear as indurated areas in pathologic specimens (sclerosis in plaques). The pathological mechanism is regarded as an autoimmune attack of the myelin sheat, mediated by both cellular and humoral immunity. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia and bladder dysfunction. Genetic and environmental factors influence susceptibility to the disease. Note=Polymorphisms in CD24 may act as a genetic modifier for susceptibility and progression of MS in some populations, perhaps by affecting the efficiency of CD24 expression on the cell surface.
Similarity : Belongs to the CD24 family.
神經干細胞標志物
腫瘤標志物 
CD24是一種低分子質量高度糖基化的黏附分子, 主要表達在造血系統. zui近研究表明, 在造血系統腫瘤和一些器官的實體瘤表面可見CD24高表達。
近幾年很多學者認為：CD24在前列腺癌、非小細胞肺癌、鼻咽癌、原發性肝細胞癌、膽管細胞癌、麥克爾細胞癌、神經源性腫瘤、胰腺癌、胃癌、結腸癌、腎細胞癌、B細胞淋巴瘤、乳腺癌等腫瘤組織中表達增強, 且和腫瘤侵襲轉移、復發和預后相關。